Immunovant, Inc. (IMVT)
22.98
-0.67
(-2.83%)
USD |
NASDAQ |
Mar 20, 16:00
22.99
+0.01
(+0.04%)
After-Hours: 20:00
Immunovant Accounts Payable (Quarterly) : 8.616M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.144B |
| Plus Therapeutics, Inc. | 5.92M |
| Viridian Therapeutics, Inc. | 8.683M |
| Nutriband, Inc. | 0.6052M |
| Definium Therapeutics, Inc. | 5.347M |